Abstract submissions are now open

Photo for abstracts page.jpg

Deadline for submissions: 

April 30-2022


Notification of acceptance status will be sent on or before: 

May 3-2022
 

Guidelines for abstract submissions
  • Abstracts should state briefly and clearly the purpose, methods, results and conclusions of the work. 

  • Abstracts must be submitted in ENGLISH. 

  • Abstracts submitted to the MENATOX congress will be subject to a peer review process before being accepted for presentation at the congress and publication in the congress booklet. This involves scoring abstracts separately using the criteria below. The final decisions are taken by the scientific committee. 

  • Following Criteria will be considered for abstracts acceptance:

    • Quality: Scientific quality will be given the highest weighting in deciding whether abstracts are accepted for presentation and particularly consideration of an oral presentation.

    • Relevance: The topic must be relevant to medical/clinical toxicology and/or poisons center activity and preferably to the MENA region; though topics of a wider geographic relevance will also be considered. 

    • Originality: Previously presented abstracts in other conferences may be accepted; however, abstracts that have been already published previously (as a journal full study article) will be declined.

    •  Content: Abstracts must contain original data or observations, or should illustrate an issue of important educational benefit or of particular interest. Abstracts that do not contain data will not be accepted for presentation or publication.

    • Language: Abstracts must be written in English.

  • Oral presentations are offered to those who have submitted the highest quality research and an indication of a preference to give an oral presentation is used as a secondary index. When assigning oral presentations, the scientific committee is looking for quality, originality and relevance in particular. 

  • The submission of case reports containing original observations is encouraged. The quality of abstracts is enhanced by a brief and balanced description of the available literature relevant to the case being presented. 

  • Some case presentations will be recommended as ‘discussed posters’, where the authors will have the opportunity to discuss their case in more detail with a discussant who is an expert bin the field.

  • Some clinical observations that are not original can sometimes be interesting and educational and may stimulate some useful debate. Such abstracts may be accepted for presentation and if they are they will be published in the congress booklet. 

  • All abstract presenters are required to register with the conference. Accepted abstracts are eligible for presentation after receiving full registration fee from the author.  If registration fee of the presenting author is not received by Thursday 17 February 2022 his/her paper is assumed to have been withdrawn.